Bottom line
Is WSGAX a good fund? The bottom line
WSGAX is the Class A share class of Nomura Small Cap Growth Fund, an actively managed small-cap mutual fund from Voya.
Annual fees run 1.1% — about $110 a year on every $10,000 invested, more expensive than 60% of small-cap funds we track.
It returned +7.1% over one year, +0.8% a year over five years, +9.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.2 billion in net assets and 84 holdings, its largest position is Mirum Pharmaceuticals Inc (2.3%) and the top 10 make up 20.8% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What to watch
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What WSGAX invests in
Nomura Small Cap Growth Fund seeks to provide growth of capital.
Nomura Small Cap Growth Fund ?seeks to achieve its objective by investing, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in common stocks of small-capitalization, growth-oriented companies (80% policy). For purposes of the Funds 80% policy, the Manager considers small-capitalization companies to be those companies with market capitalizations similar to those of issuers included in the Russell 2000 Growth Index. As of June 30, 2026, this range of market capitalization was between approximately $157.7 million and $13.8 billion. For purposes of the 80% policy, growth-oriented companies are those companies included in the Russell 2000 Growth Index or companies that exhibit characteristics similar to those companies included in the Russell 2000 Growth Index, including but not limited to relatively higher price-to-book…
From the fund's prospectus (filed Jul 29, 2026).
WSGAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| WSGAX | +7.1% | +0.8% | +9.2% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What WSGAX costs
On a $10,000 investment, WSGAX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $2,036 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
WSGAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Mirum Pharmaceuticals Inc MIRM | 2.34% |
| 2 | Pricesmart Inc PSMT | 2.23% |
| 3 | Digitalocean Holdings Inc DOCN | 2.17% |
| 4 | Firstcash Holdings Inc FCFS | 2.12% |
| 5 | Kontoor Brands Inc KTB | 2.08% |
| 6 | Agilysys Inc AGYS | 1.99% |
| 7 | Adaptive Biotechnologies Corp ADPT | 1.99% |
| 8 | Advanced Energy Industries Inc AEIS | 1.97% |
| 9 | Encompass Health Corp EHC | 1.96% |
| 10 | A10 Networks Inc ATEN | 1.93% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 20.8% of the fund. See all top 25 holdings and asset mix →